Nomura Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.35M | Buy |
33,638
+12,925
| +62% | +$903K | 0.01% | 688 |
|
|
2025
Q1 | $1.52M | Buy |
20,713
+533
| +3% | +$39.2K | ﹤0.01% | 735 |
|
|
2024
Q4 | $1.32M | Sell |
20,180
-66,990
| -77% | -$4.39M | ﹤0.01% | 766 |
|
|
2024
Q3 | $6.79M | Sell |
87,170
-3,414
| -4% | -$266K | 0.02% | 501 |
|
|
2024
Q2 | $7.06M | Buy |
90,584
+474
| +0.5% | +$37K | 0.02% | 460 |
|
|
2024
Q1 | $6.1M | Buy |
90,110
+28,580
| +46% | +$1.94M | 0.02% | 490 |
|
|
2023
Q4 | $4.14M | Buy |
61,530
+1,876
| +3% | +$126K | 0.02% | 571 |
|
|
2023
Q3 | $4.04M | Buy |
59,654
+7,596
| +15% | +$514K | 0.02% | 542 |
|
|
2023
Q2 | $3.73M | Buy |
52,058
+7,977
| +18% | +$571K | 0.02% | 572 |
|
|
2023
Q1 | $3.06M | Buy |
44,081
+22,298
| +102% | +$1.55M | 0.02% | 594 |
|
|
2022
Q4 | $1.48M | Buy |
21,783
+3,461
| +19% | +$235K | 0.01% | 749 |
|
|
2022
Q3 | $1M | Sell |
18,322
-2,057
| -10% | -$113K | 0.01% | 792 |
|
|
2022
Q2 | $1.35M | Buy |
20,379
+3,092
| +18% | +$204K | 0.01% | 779 |
|
|
2022
Q1 | $1.15M | Buy |
+17,287
| New | +$1.15M | 0.01% | 822 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1035 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1007 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1000 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 985 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 980 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 953 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 969 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 941 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 968 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1005 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 986 |
|